Metrikler
Yayın
12
Açık Erişim
5
BM Sürdürülebilir Kalkınma Amaçları
Eğitim Bilgileri
2019 - 2022
2019 - 2022Lisans Yandal
Karadeniz Teknik Üniversitesi, Tıp Fakültesi, Dahili Tıp, Türkiye
2009 - 2014
2009 - 2014Tıpta Uzmanlık
Ondokuz Mayıs Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Türkiye
2002 - 2009
2002 - 2009Lisans
Hacettepe Üniversitesi, Tıp Fakültesi (İngilizce), Türkiye
Makaleler
Tümü (12)
SCI-E, SSCI, AHCI (8)
SCI-E, SSCI, AHCI, ESCI (10)
ESCI (2)
Scopus (9)
TRDizin (1)
Diğer Yayınlar (1)
2025
20251. Altered Apoptosis in Endometriosis Compared with Ovarian Carcinoma
Ozdemir O., YILDIRIM A., TEKELİOĞLU Y., ERSÖZ Ş., GÜVEN S.
Medicina (Lithuania)
, cilt.61, sa.11, 2025 (SCI-Expanded, Scopus)
2024
20242. CDK4/6 Inhibitor-Associated Mean Corpuscular Volume Change: A Potential Parameter for Predicting Survival in Metastatic Breast Cancer?
Yildirim A., DUYGULU M. E., FİDAN E.
Journal of the College of Physicians and Surgeons Pakistan
, cilt.34, sa.7, ss.785-789, 2024 (SCI-Expanded, Scopus)
2024
20243. The Effect of Chemotherapeutic Agents on Survival in Metastatic Non-Small-Cell Lung Cancer with KRAS Mutation
DUYGULU M. E., YILDIRIM A., AYAS E., ALYILDIZ N., Mungan S., FİDAN E.
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY
, cilt.45, sa.2, ss.127-133, 2024 (ESCI, Scopus)
2024
20244. Evaluation of patient adherence with oral anticancer agents
Kazaz S. N., Yıldırım A.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
, cilt.20, sa.10.4103/jcrt.jcrt_2238_22, ss.1707-1712, 2024 (SCI-Expanded, Scopus)
2024
20245. Effect of Ki-67 proliferation index on survival in large cell neuroendocrine carcinoma of the lung
DUYGULU M. E., AŞIK E., TÜKENMEZ M. A., TEOMAN G., Yildirim A., FİDAN E.
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA
, cilt.70, sa.9, 2024 (SCI-Expanded, Scopus)
2023
20236. Factors Affecting the Efficacy of Regorafenib in Metastatic Colorectal Cancer: Is Tumour Sidedness Important?
Kazaz S. N., Özdöver A. C., Usta N., Yıldırım A., Fidan E., Özdemir F.
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN
, cilt.33, sa.6, ss.659-665, 2023 (SCI-Expanded, Scopus)
2023
20237. Anxiety Levels in Cancer Patients during the First Months of the COVID-19 Pandemic
KAZAZ S. N., YILDIRIM A.
Sağlık bilimlerinde değer (Online)
, cilt.13, sa.1, ss.87-92, 2023 (TRDizin)
2022
20228. Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study
Yekeduz E., ÖZBAY M. F., Caglayan D., YILDIRIM A., Erol C., YILDIRIM H. Ç., et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
, cilt.78, sa.12, ss.1973-1979, 2022 (SCI-Expanded, Scopus)
2022
20229. Hearing Loss After the First Low Dose Administration of Cisplatin
YILDIRIM A., FİDAN E., ÖZDEMİR F.
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN
, cilt.32, sa.9, ss.1216-1218, 2022 (SCI-Expanded, Scopus)
2022
202210. The relationship between albumin-bilirubin score and survival in patients operated for pancreatic cancer
FİDAN E., Yildirim A., Kazaz N., FİDAN S., ÇEKİÇ A. B.
JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION
, cilt.72, sa.7, ss.1340-1344, 2022 (SCI-Expanded, Scopus)
2022
202211. Evaluation of knowledge, attitudes and behaviors about COVID-19 among cancer patients
KAZAZ S. N., YILDIRIM A.
ANNALS OF CLINICAL AND ANALYTICAL MEDICINE
, sa.4, ss.389-393, 2022 (ESCI)
2017
201712. Gingival Stimulation: An Important Metabolic Regulator?
A Y., H A., A B., I D.
Journal of Obesity and Overweight , cilt.3, sa.2, ss.199-204, 2017 (Hakemli Dergi)